Hawthorne Health
Roseville, US
Hawthorne Health operates a network of 12 community-based clinical research sites and offers in-home visits to conduct clinical trials, aiming to improve patient enrollment, retention, and protocol-compliant data. It serves study sponsors across therapeutic areas including cardiovascular, dermatology, immunology, neurology, and rare disease.</parameter> <parameter name="founders">[]
BiotechDigital HealthHealthtech
Founders & leadership
JR
Joshua RoseExecutive Officer, Director
LC
Lucy CoassinResigned as director on 02/18/2026.
JA
Jodi AkinDirector
JD
Jonathan DiVincenzoDirector
AC
Antonio ClapsisDirector
MM
Maddie MaloneyResigned as director on 02/18/2026.
AJ
Andrea JacksonAppointed as director on 02/18/2026.
RD
Richard DalyAppointed as director on 02/18/2026.
Reported raises · per SEC filings
Form D private placements▶$10.7KraisedAug 2026 · 1 investors · Other Health CareRule 506(b)
▶$10.7KraisedAug 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joshua RoseExecutive Officer, Director
- Lucy CoassinDirector
- Jodi AkinDirector
- Jonathan DiVincenzoDirector
- Antonio ClapsisDirector
- Maddie MaloneyDirector
- Andrea JacksonDirector
- Richard DalyDirector
- Amount sold
- $10.7K
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedAug 2026 · 6 investors · Other Health CareRule 506(b)
▶$2.5MraisedAug 2026 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joshua RoseExecutive Officer, Director
- Lucy CoassinDirector
- Jodi AkinDirector
- Jonathan DiVincenzoDirector
- Antonio ClapsisDirector
- Maddie MaloneyDirector
- Andrea JacksonDirector
- Richard DalyDirector
- Offering amount
- $5.5M
- Amount sold
- $2.5M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.